Offerpad Solutions Receives NYSE Delisting Warning for Sub-$1.00 Stock Price
summarizeSummary
Offerpad Solutions Inc. received a notice from the NYSE for failing to meet the minimum $1.00 average stock price requirement, initiating a six-month cure period to regain compliance.
check_boxKey Events
-
NYSE Non-Compliance Notice Received
On March 3, 2026, Offerpad Solutions Inc. was notified by the NYSE that its Class A common stock traded below an average closing price of $1.00 for 30 consecutive trading days, violating Section 802.01C of the NYSE Listed Company Manual.
-
Six-Month Cure Period Initiated
The notice does not result in immediate delisting. The company has a six-month period to regain compliance by achieving a closing share price of at least $1.00 and an average closing price of at least $1.00 over 30 trading days by the end of any calendar month.
-
Reverse Stock Split Under Consideration
Offerpad intends to cure the deficiency and will consider available alternatives, including a reverse stock split, subject to stockholder approval, if necessary to meet the listing standard.
auto_awesomeAnalysis
Offerpad Solutions Inc. has received a formal notice from the NYSE regarding non-compliance with the minimum $1.00 average closing price rule. This is a critical development, formalizing a delisting threat previously mentioned in the company's 10-K. While not an immediate delisting, it places significant pressure on the company to raise its stock price within a six-month cure period. The consideration of a reverse stock split, a common tactic for micro-cap companies facing delisting, often signals underlying financial distress and can be viewed negatively by investors due to its potential for further share price volatility and psychological impact. This event adds to the company's challenges, following recent reports of revenue decline and net losses.
At the time of this filing, OPAD was trading at $0.75 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $35.4M. The 52-week trading range was $0.71 to $6.35. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.